Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Apple
AAPL
|
+$1.35B |
| 2 |
Microsoft
MSFT
|
+$1.33B |
| 3 |
S&P Global
SPGI
|
+$898M |
| 4 |
Advanced Micro Devices
AMD
|
+$845M |
| 5 |
Tesla
TSLA
|
+$823M |
Top Sells
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$1.08B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$972M |
| 3 |
Merck
MRK
|
+$307M |
| 4 |
Exelon
EXC
|
+$291M |
| 5 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$205M |
Sector Composition
| 1 | Technology | 25.4% |
| 2 | Financials | 13.31% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 11.44% |
| 5 | Communication Services | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Columbia Financial
CLBK
$1.61B
| $17M | ﹤0.01% |
789,518
+11,210
| +1% | +$241K |
|
|
AVTA
2002
DELISTED
Avantax, Inc. Common Stock
AVTA
| $17M | ﹤0.01% |
867,811
+28,314
| +3% | +$554K |
|
2003
Cars.com
CARS
$847M
| $16.9M | ﹤0.01% |
1,171,499
+35,882
| +3% | +$518K |
|
|
PYCR
2004
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $16.9M | ﹤0.01% |
579,007
+82,191
| +17% | +$2.39M |
|
2005
Kearny Financial
KRNY
$421M
| $16.8M | ﹤0.01% |
1,302,182
+16,077
| +1% | +$207K |
|
2006
XPEL
XPEL
$993M
| $16.8M | ﹤0.01% |
318,658
+10,444
| +3% | +$549K |
|
2007
Quanterix
QTRX
$223M
| $16.7M | ﹤0.01% |
573,548
+4,288
| +0.8% | +$125K |
|
2008
MannKind Corp
MNKD
$1.66B
| $16.7M | ﹤0.01% |
4,534,505
+263,447
| +6% | +$969K |
|
|
NTUS
2009
DELISTED
Natus Medical Inc
NTUS
| $16.7M | ﹤0.01% |
634,905
+28,753
| +5% | +$756K |
|
2010
Origin Bancorp
OBK
$1.1B
| $16.6M | ﹤0.01% |
393,493
+11,436
| +3% | +$484K |
|
|
IMGN
2011
DELISTED
Immunogen Inc
IMGN
| $16.6M | ﹤0.01% |
3,489,369
-57,398
| -2% | -$273K |
|
|
ACCD
2012
DELISTED
Accolade, Inc. Common Stock
ACCD
| $16.6M | ﹤0.01% |
945,428
-7,496
| -0.8% | -$132K |
|
2013
Metallus
MTUS
$710M
| $16.5M | ﹤0.01% |
755,723
+40,024
| +6% | +$876K |
|
2014
Great Lakes Dredge & Dock
GLDD
$834M
| $16.5M | ﹤0.01% |
1,176,750
+1,551
| +0.1% | +$21.8K |
|
2015
CEVA Inc
CEVA
$570M
| $16.5M | ﹤0.01% |
405,399
+11,231
| +3% | +$457K |
|
2016
Krispy Kreme
DNUT
$539M
| $16.5M | ﹤0.01% |
1,109,665
+547,270
| +97% | +$8.13M |
|
2017
Gevo
GEVO
$401M
| $16.4M | ﹤0.01% |
3,512,691
+200,398
| +6% | +$938K |
|
2018
Adtran
ADTN
$849M
| $16.4M | ﹤0.01% |
889,429
+45,693
| +5% | +$843K |
|
2019
CNA Financial
CNA
$13B
| $16.4M | ﹤0.01% |
336,402
+12,885
| +4% | +$626K |
|
2020
LeMaitre Vascular
LMAT
$2.13B
| $16.3M | ﹤0.01% |
351,435
-3,052
| -0.9% | -$142K |
|
2021
Orion
OEC
$581M
| $16.3M | ﹤0.01% |
1,020,909
-27,649
| -3% | -$442K |
|
2022
Anterix
ATEX
$405M
| $16.3M | ﹤0.01% |
280,694
+13,024
| +5% | +$754K |
|
2023
Crinetics Pharmaceuticals
CRNX
$3.18B
| $16.3M | ﹤0.01% |
740,385
+41,647
| +6% | +$914K |
|
|
MODN
2024
DELISTED
MODEL N, INC.
MODN
| $16.2M | ﹤0.01% |
603,682
+38,985
| +7% | +$1.05M |
|
2025
Usana Health Sciences
USNA
$564M
| $16.2M | ﹤0.01% |
204,240
-7,712
| -4% | -$613K |
|